4.7 Review

Acquired channelopathies as contributors to development and progression of multiple sclerosis

Journal

EXPERIMENTAL NEUROLOGY
Volume 262, Issue -, Pages 28-36

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.expneurol.2013.12.006

Keywords

Multiple sclerosis; Experimental autoimmune encephalomyelitis; Ion channels; Neurodegeneration; CNS inflammation

Categories

Funding

  1. Deutsche Forschungsgemeinschaft Emmy Noether-Programme [FR1720/3-1]
  2. Gemeinnutzige Hertie-Stiftung [1.01.1/11/003, P1130075]
  3. Werner Otto Stiftung
  4. Forschung- und Wissenschaftsstiftung Hamburg
  5. Boehringer Ingelheim Stiftung Exploration Grant

Ask authors/readers for more resources

Multiple sclerosis (MS), the most frequent inflammatory disease of the central nervous system (CNS), affects about two and a half million individuals worldwide and causes major burdens to the patients, which develop the disease usually at the age of 20 to 40. MS is likely referable to a breakdown of immune cell tolerance to CNS self-antigens resulting in focal immune cell infiltration, activation of microglia and astrocytes, demyelination and axonal and neuronal loss. Here we discuss how altered expression patterns and dysregulated functions of ion channels contribute on a molecular level to nearly all pathophysiological steps of the disease. In particular the detrimental redistribution of ion channels along axons, as well as neuronal excitotoxicity with regard to imbalanced glutamate homeostasis during chronic CNS inflammation will be discussed in detail. Together, we describe which ion channels in the immune and nervous system commend as attractive future drugable targets in MS treatment. (C) 2013 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available